LYS Labs recently announced its seed round with participation from Alchemy Ventures, Auros Global, and Frachtis, among others, expanded its ecosystem through integrations with QuickNode, and joined ...

But developing new AI products isn't cheap. Atlassian's fourth-quarter operating costs grew by 20% year over year to $1.17 billion, with research and development making up the lion's share of that ...

Artificial Intelligence (AI) has quickly made its way into the world of investing. What was once the domain of professional ...

STARBASE, Texas — During a presentation, SpaceX CEO and founder Elon Musk shared how he plans to use Starship to reach the planet Mars, and how in a few short years, there is a chance humans could ...

With AI chatbots growing in popular usage, it was only a matter of time before large numbers of people began applying them to ...

Application security posture management company Apiiro Ltd. today announced a new update that aims to help enterprises get ...

Many retail myths around product launches still persist—from overstocking safety stock to over-relying on historical data.

U.S. stocks ended modestly lower Friday after a weak jobs report cemented the case for a Federal Reserve rate cut at the central bank's policy meeting ending Sept. 17. Bond yields declined sharply.

U.S. stock futures were trading mixed early Thursday as markets reacted to a federal judge’s decision allowing Alphabet’s (GOOGL) Google to retain its Chrome browser. At the same time, traders ...

With a background in journalism and counseling, Penny Min blends analytical research with real-world insight to help readers make informed financial decisions. At Forbes Marketplace, she specializes ...

EMJ Capital's Eric Jackson compared Opendoor to Uber and Airbnb on a Yahoo! Finance show. While there are parallels, there are also key differences. The meme stock is on the move again today, ...

Shares of Cytokinetics, Inc. CYTK are trading sharply higher Tuesday after the biopharmaceutical company presented new data highlighting the long-term safety and efficacy of its investigational drug, ...